Literature DB >> 9093343

Effects of airway infection by Pseudomonas aeruginosa: a computed tomographic study.

K A Miszkiel1, A U Wells, M B Rubens, P J Cole, D M Hansell.   

Abstract

BACKGROUND: Pseudomonas aeruginosa commonly infects the airways of patients with bronchiectasis. A study was undertaken to examine the relationship between infection of the airways with this pathogen, the morphological pattern of bronchiectasis on thin section computed tomographic (CT) scanning, symptom duration, smoking habits of the patients, and the presence of airflow obstruction.
METHODS: Thin section CT scans of 22 adult patients with bronchiectasis and concurrent sputum infected by P aeruginosa (Pa +ve) and those of 45 randomly selected patients not infected by P aeruginosa (Pa -ve) were analysed independently by two thoracic radiologists. Patients with cystic fibrosis were excluded. Each scan was scored at a lobar level for extent of bronchiectasis, severity of bronchial wall thickening and dilatation, predominant pattern of bronchiectasis, presence of mucus plugging, and degree of decreased attenuation of the lung parenchyma.
RESULTS: The Pa +ve group had more extensive bronchiectasis and a greater degree of bronchial wall thickening and dilatation on the CT scan than the Pa -ve group; more extensive decreased attenuation was seen in the Pa +ve group. These findings were robust on multivariate analysis; decreased attenuation was also independently related to the duration of sputum production.
CONCLUSION: Patients with bronchiectasis infected by P aeruginosa have more extensive and severe bronchiectasis on thin section CT scanning than those without P aeruginosa infection. The bronchi and small airways are both involved, reflecting the end result of complex interactions between host airways and the numerous virulence factors produced by P aeruginosa.

Entities:  

Mesh:

Year:  1997        PMID: 9093343      PMCID: PMC1758513          DOI: 10.1136/thx.52.3.260

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  23 in total

1.  Statistical methods for assessing observer variability in clinical measures.

Authors:  P Brennan; A Silman
Journal:  BMJ       Date:  1992-06-06

2.  High resolution CT and bronchography in the assessment of bronchiectasis.

Authors:  K Young; F Aspestrand; A Kolbenstvedt
Journal:  Acta Radiol       Date:  1991-11       Impact factor: 1.990

Review 3.  High-resolution computed tomography of the airways.

Authors:  P Grenier; M P Cordeau; C Beigelman
Journal:  J Thorac Imaging       Date:  1993       Impact factor: 3.000

4.  Efficacy and safety of long-term ciprofloxacin in the management of severe bronchiectasis.

Authors:  C F Rayner; G Tillotson; P J Cole; R Wilson
Journal:  J Antimicrob Chemother       Date:  1994-07       Impact factor: 5.790

5.  Bronchiectasis: functional significance of areas of decreased attenuation at expiratory CT.

Authors:  D M Hansell; A U Wells; M B Rubens; P J Cole
Journal:  Radiology       Date:  1994-11       Impact factor: 11.105

6.  Effect of Pseudomonas aeruginosa rhamnolipids on mucociliary transport and ciliary beating.

Authors:  R C Read; P Roberts; N Munro; A Rutman; A Hastie; T Shryock; R Hall; W McDonald-Gibson; V Lund; G Taylor
Journal:  J Appl Physiol (1985)       Date:  1992-06

7.  Stimulation of secretion into human and feline airways by Pseudomonas aeruginosa proteases.

Authors:  M Somerville; P S Richardson; A Rutman; R Wilson; P J Cole
Journal:  J Appl Physiol (1985)       Date:  1991-05

8.  Role of chronic Pseudomonas aeruginosa infection in the development of bronchiectasis.

Authors:  M Nagaki; S Shimura; Y Tanno; T Ishibashi; H Sasaki; T Takishima
Journal:  Chest       Date:  1992-11       Impact factor: 9.410

9.  Effects of human neutrophil elastase and Pseudomonas aeruginosa proteinases on human respiratory epithelium.

Authors:  R Amitani; R Wilson; A Rutman; R Read; C Ward; D Burnett; R A Stockley; P J Cole
Journal:  Am J Respir Cell Mol Biol       Date:  1991-01       Impact factor: 6.914

10.  Interaction of Pseudomonas aeruginosa with human respiratory mucosa in vitro.

Authors:  K W Tsang; A Rutman; E Tanaka; V Lund; A Dewar; P J Cole; R Wilson
Journal:  Eur Respir J       Date:  1994-10       Impact factor: 16.671

View more
  9 in total

1.  Bacterial colonisation in patients with bronchiectasis: microbiological pattern and risk factors.

Authors:  J Angrill; C Agustí; R de Celis; A Rañó; J Gonzalez; T Solé; A Xaubet; R Rodriguez-Roisin; A Torres
Journal:  Thorax       Date:  2002-01       Impact factor: 9.139

2.  Association between mucoid Pseudomonas infection and bronchiectasis in children with cystic fibrosis.

Authors:  Philip M Farrell; Jannette Collins; Lynn S Broderick; Michael J Rock; Zhanhai Li; Michael R Kosorok; Anita Laxova; William M Gershan; Alan S Brody
Journal:  Radiology       Date:  2009-08       Impact factor: 11.105

3.  Relationships between high-resolution computed tomography, lung function and bacteriology in stable bronchiectasis.

Authors:  Jin-Hwa Lee; Yoo-Kyung Kim; Hyon-Ju Kwag; Jung-Hyun Chang
Journal:  J Korean Med Sci       Date:  2004-02       Impact factor: 2.153

4.  Inhaled colistin in patients with bronchiectasis and chronic Pseudomonas aeruginosa infection.

Authors:  Charles S Haworth; Juliet E Foweraker; Peter Wilkinson; Robert F Kenyon; Diana Bilton
Journal:  Am J Respir Crit Care Med       Date:  2014-04-15       Impact factor: 21.405

5.  Bronchiectasis: a bacteriological profile.

Authors:  Régis Gothard Bopaka; Wiam El Khattabi; Hind Janah; Hasna Jabri; Hicham Afif
Journal:  Pan Afr Med J       Date:  2015-12-17

6.  Tolerability and Pharmacokinetic Evaluation of Inhaled Dry Powder Tobramycin Free Base in Non-Cystic Fibrosis Bronchiectasis Patients.

Authors:  Marcel Hoppentocht; Onno W Akkerman; Paul Hagedoorn; Jan-Willem C Alffenaar; Tjip S van der Werf; Huib A M Kerstjens; Henderik W Frijlink; Anne H de Boer
Journal:  PLoS One       Date:  2016-03-09       Impact factor: 3.240

7.  Bacterial colonization and associated factors in patients with bronchiectasis.

Authors:  Sermin Borekci; Ayse Nigar Halis; Gokhan Aygun; Benan Musellim
Journal:  Ann Thorac Med       Date:  2016 Jan-Mar       Impact factor: 2.219

8.  Pseudomonas aeruginosa isolation in patients with non-cystic fibrosis bronchiectasis: a retrospective study.

Authors:  Hong Wang; Xiao-Bin Ji; Bei Mao; Cheng-Wei Li; Hai-Wen Lu; Jin-Fu Xu
Journal:  BMJ Open       Date:  2018-03-14       Impact factor: 2.692

9.  Predicting factors for chronic colonization of Pseudomonas aeruginosa in bronchiectasis.

Authors:  A Pieters; M Bakker; R A S Hoek; J Altenburg; M van Westreenen; J G J V Aerts; M M van der Eerden
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-08-31       Impact factor: 3.267

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.